share_log

Several Insiders Invested In Teladoc Health Flagging Positive News

Several Insiders Invested In Teladoc Health Flagging Positive News

幾位內部人士投資了Teladoc Health標誌着積極的資訊
Simply Wall St ·  11/02 22:20

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like they did in the case of Teladoc Health, Inc. (NYSE:TDOC), that sends out a positive message to the company's shareholders.

通常情況下,當一名內部人士購買股票時,這可能不是一個重大事件。但是當多名內部人士像在Teladoc Health, Inc. (紐交所:TDOC)的情況下一樣購買股票時,這向公司的股東發送了積極的信息。

While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.

雖然內部交易並非長期投資中最重要的事情,但我們認爲跟蹤內部人士的行爲是完全合理的。

Teladoc Health Insider Transactions Over The Last Year

過去一年Teladoc Health內部交易

The Independent Director Thomas McKinley made the biggest insider purchase in the last 12 months. That single transaction was for US$82k worth of shares at a price of US$7.57 each. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of US$9.21. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive.

獨立董事Thomas McKinley在過去12個月中進行了最大的內部交易購買。那筆交易金額爲8.2萬美元,每股價格爲7.57美元。儘管我們很高興看到內部人士的購買行爲,但我們注意到這筆大宗購買的價格遠低於最近的9.21美元。因爲這是以更低的估值完成的,這並不能告訴我們內部人士是否認爲今天的價格有吸引力。

Over the last year, we can see that insiders have bought 19.00k shares worth US$141k. But insiders sold 1.87k shares worth US$24k. In total, Teladoc Health insiders bought more than they sold over the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

過去一年,我們看到內部人士購買了1.9萬股價值14.1萬美元。但內部人士賣出了0.187萬股,價值2.4萬美元。總體而言,Teladoc Health內部人士在過去一年中的買入超過了賣出。您可以在下面看到過去12個月內部交易的視覺呈現(按公司和個人)。如果想確切了解誰賣出了多少股,以及何時賣出,請單擊下方的圖表!

big
NYSE:TDOC Insider Trading Volume November 2nd 2024
紐交所:TDOC內幕交易成交量2024年11月2日

Teladoc Health is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.

Teladoc Health並不是唯一一家有內部人士在買入股票的公司。對於喜歡發現小盤公司具有吸引力估值的人來說,這份免費的快速增長有內部人士購入股票的公司列表可能正合適。

Teladoc Health Insiders Bought Stock Recently

teladoc health內部人士最近購入股票

It's good to see that Teladoc Health insiders have made notable investments in the company's shares. Not only was there no selling that we can see, but they collectively bought US$141k worth of shares. This is a positive in our book as it implies some confidence.

看到Teladoc Health內部人士對公司股票做出重要投資是件好事。我們不僅看不到任何賣出,而且他們共同購入了價值14.1萬美元的股票。這在我們看來是積極的,表明了一些信心。

Insider Ownership

內部人員持股情況

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. I reckon it's a good sign if insiders own a significant number of shares in the company. Teladoc Health insiders own about US$14m worth of shares. That equates to 0.9% of the company. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

查看公司內部持股總量可以幫助了解他們是否與普通股東利益一致。我認爲,如果內部人士在公司擁有大量股份,這是一個好跡象。teladoc health內部人士持有價值約1400萬美元的股份。這相當於公司的0.9%。雖然這是一個強勢但不是傑出的內部持股水平,但足以表明管理層與較小股東之間存在一定的利益一致。

So What Does This Data Suggest About Teladoc Health Insiders?

那麼這些數據對於teladoc health內部人士意味着什麼?

The recent insider purchases are heartening. And an analysis of the transactions over the last year also gives us confidence. But on the other hand, the company made a loss during the last year, which makes us a little cautious. When combined with notable insider ownership, these factors suggest Teladoc Health insiders are well aligned, and that they may think the share price is too low. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. To assist with this, we've discovered 2 warning signs that you should run your eye over to get a better picture of Teladoc Health.

最近內部人士的買入令人振奮。而對過去一年交易的分析也讓我們充滿信心。但另一方面,公司在過去一年中虧損,這使我們有些謹慎。結合顯著的內部持股,這些因素表明teladoc health內部人士是合理對齊的,並且他們可能認爲股價過低。雖然了解內部人士的持股和交易情況很重要,但在做出任何投資決策之前,我們必須確保考慮到股票面臨的風險。爲了幫助這一點,我們發現了2個警示信號,您應該仔細審視,以更好地了解teladoc health。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

當然,您可能會在其他地方找到一項出色的投資。因此,請查看此免費的有趣公司列表。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

對於本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論